-
A new national report indicates many at-risk teens are missing needed reproductive health services.
-
According to results of a national survey, physicians recommend human papillomavirus (HPV) vaccination to less than 15% of their male patients ages 9-26. Pediatric specialists and doctors who support new vaccines were more likely to recommend the vaccine, data indicate.
-
The Duke Clinical Research Institute is working with nine centers across the United States in a five-year project to evaluate the effectiveness of different treatment strategies for women with uterine fibroids.
-
Near the end of September 2014, the American Academy of Pediatrics (AAP) published its policy statement on contraception for adolescents.
-
Teens who received free contraception and were educated about the benefits and disadvantages of various birth control methods in the Contraceptive CHOICE Project in St. Louis were dramatically less likely to get pregnant, give birth, or obtain an abortion compared with other sexually active teens, data suggests in a just-released study.
-
Ascites, gastrointestinal hemorrhage, hepatic encephalopathy and bacterial infections are common complications experienced by patients with cirrhosis. Traditionally, when a cirrhotic patient experiences one of these complications and develops worsening liver function, he or she is diagnosed with acute on chronic liver failure.
-
In an earlier study of early decompressive hemicraniectomy for large middle cerebral artery strokes, the same investigators demonstrated reduced mortality without increasing the risk of very severe disability among patients ≤ 60 years of age.
-
After pelvic floor reconstructive surgery, antibiotic prophylaxis with daily nitrofurantoin during postoperative catheterization does not decrease risk of urinary tract infection.
-
This was a retrospective cohort study from Quebec and Ontario, Canada, examining patients ≥ 65 years of age admitted to a hospital with a diagnosis of atrial fibrillation (AF) between 1998 and 2007.
-
Recent controversy has erupted concerning the use of prophylactic beta-blockers in patients with known or suspected coronary artery disease (CAD) undergoing non-cardiac surgery.
